Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin
Clinical trial NCT05504226 · COMPLETED
Trial details
- NCT number
- NCT05504226
- Sponsor
- Handok Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-11-30
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.